Literature DB >> 15357219

DNA topoisomerases in life and death: implications in kinetoplastid protozoa.

Arnab Roy Chowdhury1, Hemanta K Majumder.   

Abstract

Current biomedical research has its focus on the search for newer intervention strategies to control public health impact of parasitic diseases. The dramatic advances of molecular and cellular biology in recent times have provided opportunities for discovering and evaluating molecular targets for drug designing, which now form a rational basis for the development of improved anti parasitic therapy. DNA topoisomerases, the "cellular magicians" involved in nearly all biological processes governing DNA, have emerged as one such biological target. Over the last two decades, interest in topoisomerases has expanded beyond the realm of the basic science laboratory into the clinical arena. This review aims at providing a comprehensive insight into the biology of DNA topoisomerases and also focus on its evolution as a drug target in the unicellular kinetoplastids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15357219     DOI: 10.2174/1566524043360302

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  4 in total

1.  Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide.

Authors:  Tanushri Sengupta; Mandira Mukherjee; Aditi Das; Chhabinath Mandal; Rakhee Das; Tanmoy Mukherjee; Hemanta K Majumder
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 2.  State of the art in African trypanosome drug discovery.

Authors:  Robert T Jacobs; Bakela Nare; Margaret A Phillips
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

3.  Topoisomerase II-alpha expression increases with increasing Gleason score and with hormone insensitivity in prostate carcinoma.

Authors:  C Hughes; A Murphy; C Martin; E Fox; M Ring; O Sheils; B Loftus; J O'Leary
Journal:  J Clin Pathol       Date:  2006-03-23       Impact factor: 3.411

4.  Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy.

Authors:  John C Cheville; R Jeffrey Karnes; Terry M Therneau; Farhad Kosari; Jan-Marie Munz; Lori Tillmans; Eati Basal; Laureano J Rangel; Eric Bergstralh; Irina V Kovtun; C D Savci-Heijink; Eric W Klee; George Vasmatzis
Journal:  J Clin Oncol       Date:  2008-08-20       Impact factor: 44.544

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.